CONMED CORPORATION Noncash or Part Noncash Acquisition, Intangible Assets Acquired
CONMED CORPORATION (CNMD) reported Noncash or Part Noncash Acquisition, Intangible Assets Acquired of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-22.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1 · last filed 2022-02-22
- CONMED CORPORATION noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-12-31 was $0.00.
- CONMED CORPORATION noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-09-30 was $5.64M.
- CONMED CORPORATION noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-06-30 was -$5.50M, a 134.70% decline year-over-year.
- CONMED CORPORATION noncash or part noncash acquisition, intangible assets acquired for the quarter ending 2019-03-31 was $5.50M, a 45.00% decline year-over-year.
- CONMED CORPORATION noncash or part noncash acquisition, intangible assets acquired for fiscal 2021 was $0.00.
- CONMED CORPORATION noncash or part noncash acquisition, intangible assets acquired for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
- CONMED CORPORATION noncash or part noncash acquisition, intangible assets acquired for fiscal 2019 was $5.64M, a 32.55% decline from fiscal 2018.
- CONMED CORPORATION noncash or part noncash acquisition, intangible assets acquired for fiscal 2018 was $8.36M.
| Period end | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 9 month | Noncash or Part Noncash Acquisition, Intangible Assets Acquired 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-02-22 | |||
| 2020-12-31 | $0.00 10-K · filed 2022-02-22 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-22 | $5.64M derived: sum of 2 quarters · filed 2022-02-22 | $139.00K derived: sum of 3 quarters · filed 2022-02-22 | $5.64M 10-K · filed 2022-02-22 |
| 2019-09-30 | $5.64M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $139.00K derived: sum of 2 quarters · filed 2019-10-31 | $5.64M 10-Q · filed 2019-10-31 | -$11.85M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-06-30 | -$5.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $0.00 10-Q · filed 2019-08-01 | -$17.49M derived: sum of 3 quarters · filed 2021-02-22 | -$17.49M derived: sum of 4 quarters · filed 2021-02-22 |
| 2019-03-31 | $5.50M 10-Q · filed 2019-04-26 | -$11.99M derived: sum of 2 quarters · filed 2021-02-22 | -$11.99M derived: sum of 3 quarters · filed 2021-02-22 | $3.86M derived: sum of 4 quarters · filed 2021-02-22 |
| 2018-12-31 | -$17.49M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-22 | -$17.49M derived: sum of 2 quarters · filed 2021-02-22 | -$1.64M derived: sum of 3 quarters · filed 2021-02-22 | $8.36M 10-K · filed 2021-02-22 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | $15.85M derived: sum of 2 quarters · filed 2019-10-31 | $25.85M 10-Q · filed 2019-10-31 | $25.85M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $15.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | $25.85M 10-Q · filed 2019-08-01 | $25.85M derived: sum of 3 quarters · filed 2020-02-24 | $25.85M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $10.00M 10-Q · filed 2019-04-26 | $10.00M derived: sum of 2 quarters · filed 2020-02-24 | $10.00M derived: sum of 3 quarters · filed 2020-02-24 | $10.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 10-K · filed 2020-02-24 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-02 | $0.00 derived: sum of 2 quarters · filed 2018-11-02 | $0.00 10-Q · filed 2018-11-02 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | $0.00 10-Q · filed 2018-08-02 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-04-26 | |||
| 2016-12-31 | $0.00 10-K · filed 2019-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B |